BioSpace News Archive

Deals

Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation

The Board of Directors of Calliditas Therapeutics AB unanimously recommends that the shareholders and holders of American Depositary Shares of Calliditas Therapeutics AB accept the public tender offer by Asahi Kasei Corporation.

May 28, 2024
·
24 min read
Biotech Beach

MediciNova Announces Two Poster Presentations at the 92nd EAS Congress 2024, the Annual Meeting of the European Atherosclerosis Society Regarding the Use of MN-001 (Tipelukast) for Cardiometabolic Conditions

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the Standard Market of the Tokyo Stock Exchange, announced that MediciNova conducted two poster presentations at the 92nd European Atherosclerosis Society 2024 Congress held online May 26-29, 2024.

May 28, 2024
·
9 min read
Pharm Country

West to Participate in Upcoming June 2024 Investor Conference

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will present at the William Blair 44th Annual Growth Stock Conference in Chicago, IL on Tuesday, June 4, 2024 at 8:00 AM CT.

May 28, 2024
·
1 min read
Genetown

Insulet to Present at the 2024 Jefferies Global Healthcare Conference

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that management will present at the Jefferies Global Healthcare Conference in New York City on Thursday, June 6, 2024 at 9:00 a.m.

May 28, 2024
·
1 min read
Drug Development

Arrowhead Pharmaceuticals Presents New Phase 2 Data of Plozasiran in Patients with Mixed Hyperlipidemia

Arrowhead Pharmaceuticals, Inc. announced results from the Phase 2b double blind, randomized MUIR study of investigational plozasiran in patients with mixed hyperlipidemia.

May 28, 2024
·
10 min read
Pharm Country

Immunic to Participate in Industry and Scientific Conferences in June 2024

Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced participation in the following industry and scientific conferences in June:

May 28, 2024
·
5 min read
Business

Santhera Publishes Annual Report 2023

Santhera Pharmaceuticals announces the publication of its Annual Report 2023 with fully audited results for the year ended December 31, 2023.

May 28, 2024
·
2 min read
Policy

Santhera Publishes Agenda for its Annual General Meeting 2024

Santhera Pharmaceuticals published the invitation to its Annual General Meeting, which will be held on June 18, 2024, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Switzerland.

May 28, 2024
·
2 min read
Innate Pharma Announces Its Participation in Upcoming June 2024 Investor Conferences

Regulatory News: Innate Pharma SA announced members of its executive team are scheduled to participate in the upcoming conferences, detailed below.

May 28, 2024
·
3 min read
Sensorion Announces its Participation in Upcoming Investor Conferences in June 2024

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces its participation in various investor conferences taking place in June 2024.

May 28, 2024
·
3 min read